SE8502876L - TUMOR DEVELOPMENT INHIBITION - Google Patents

TUMOR DEVELOPMENT INHIBITION

Info

Publication number
SE8502876L
SE8502876L SE8502876A SE8502876A SE8502876L SE 8502876 L SE8502876 L SE 8502876L SE 8502876 A SE8502876 A SE 8502876A SE 8502876 A SE8502876 A SE 8502876A SE 8502876 L SE8502876 L SE 8502876L
Authority
SE
Sweden
Prior art keywords
tumor development
development inhibition
vitro
tumor
toxic
Prior art date
Application number
SE8502876A
Other languages
Unknown language ( )
Swedish (sv)
Other versions
SE468501B (en
SE8502876D0 (en
Inventor
A Gaffar
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of SE8502876D0 publication Critical patent/SE8502876D0/en
Publication of SE8502876L publication Critical patent/SE8502876L/en
Publication of SE468501B publication Critical patent/SE468501B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Non-toxic-soluble pharmaceutically acceptable compound derivative of peroxydiphosphoric acid when administered orally or systematically inhibits tumor development of tumor cells in vitro and actual tumor development in vitro in warm blooded animals.
SE8502876A 1984-06-27 1985-06-11 APPLICATION OF DERIVATIVES OF PEROXIDIFOSOIC ACID FOR INHIBITION OF TUMOR DEVELOPMENT SE468501B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62506784A 1984-06-27 1984-06-27
US72654585A 1985-04-24 1985-04-24

Publications (3)

Publication Number Publication Date
SE8502876D0 SE8502876D0 (en) 1985-06-11
SE8502876L true SE8502876L (en) 1985-12-28
SE468501B SE468501B (en) 1993-02-01

Family

ID=27089811

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8502876A SE468501B (en) 1984-06-27 1985-06-11 APPLICATION OF DERIVATIVES OF PEROXIDIFOSOIC ACID FOR INHIBITION OF TUMOR DEVELOPMENT

Country Status (26)

Country Link
JP (1) JPH0623108B2 (en)
KR (1) KR880002266B1 (en)
AT (1) AT392002B (en)
AU (1) AU578104B2 (en)
BE (1) BE902732A (en)
CH (1) CH668361A5 (en)
DE (1) DE3523263A1 (en)
DK (1) DK168191B1 (en)
ES (1) ES8801122A1 (en)
FI (1) FI84697C (en)
FR (1) FR2566665B1 (en)
GB (1) GB2161074B (en)
GR (1) GR851575B (en)
IE (1) IE58434B1 (en)
IL (1) IL75518A0 (en)
IT (1) IT1209961B (en)
LU (1) LU85976A1 (en)
MA (1) MA20467A1 (en)
MC (1) MC1672A1 (en)
NL (1) NL8501840A (en)
NZ (1) NZ212301A (en)
PH (1) PH25613A (en)
PT (1) PT80707B (en)
SE (1) SE468501B (en)
WO (1) WO1986000225A1 (en)
ZW (1) ZW9585A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3528379A1 (en) * 1985-08-07 1987-02-12 Peter Berger Composition for the treatment of aqueous systems and for the regeneration of body cells
FR2586350B1 (en) * 1985-08-22 1992-05-15 Colgate Palmolive Co PHARMACEUTICAL COMPOSITION BASED ON PEROXODIPHOSPHATE FOR INHIBITION OF SECRETION OF PARATHYROIDIAN HORMONE
DE3627759A1 (en) * 1985-08-22 1987-03-19 Colgate Palmolive Co PHARMACEUTICAL COMPOSITION FOR INACTIVATING BACTERIAL ENDOTOXINS
DE4201858A1 (en) * 1992-01-24 1993-07-29 Renschler Aloys Dr Med AGENT FOR TREATING MALIGNER CELLS
KR100426450B1 (en) * 2002-03-16 2004-04-13 박래옥 Anticancer Composition Comprising Citric acid, Albumin And Zinc

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4041149A (en) * 1976-01-12 1977-08-09 Colgate-Palmolive Company Composition and method of controlling and preventing mouth odor
US4430325A (en) * 1981-12-23 1984-02-07 Colgate-Palmolive Company Topical treatment of skin lesions

Also Published As

Publication number Publication date
ATA188385A (en) 1990-07-15
FR2566665B1 (en) 1988-10-21
IE58434B1 (en) 1993-09-22
JPH0623108B2 (en) 1994-03-30
LU85976A1 (en) 1986-01-24
GB2161074B (en) 1988-04-07
ES544565A0 (en) 1988-01-01
DK168191B1 (en) 1994-02-28
CH668361A5 (en) 1988-12-30
FI852504L (en) 1985-12-28
MC1672A1 (en) 1986-06-03
DK248085A (en) 1985-12-28
GR851575B (en) 1985-11-25
AU4418785A (en) 1986-01-02
ES8801122A1 (en) 1988-01-01
JPS6140217A (en) 1986-02-26
KR880002266B1 (en) 1988-10-21
DE3523263A1 (en) 1986-01-09
NL8501840A (en) 1986-01-16
BE902732A (en) 1985-12-24
PT80707B (en) 1986-12-09
FI852504A0 (en) 1985-06-25
AU578104B2 (en) 1988-10-13
SE468501B (en) 1993-02-01
AT392002B (en) 1991-01-10
IT8548226A0 (en) 1985-06-17
GB8515105D0 (en) 1985-07-17
IE851597L (en) 1985-12-27
NZ212301A (en) 1988-04-29
FI84697B (en) 1991-09-30
FI84697C (en) 1992-01-10
IT1209961B (en) 1989-08-30
PT80707A (en) 1985-07-01
ZW9585A1 (en) 1985-11-13
PH25613A (en) 1991-08-08
KR860000070A (en) 1986-01-25
DK248085D0 (en) 1985-06-03
FR2566665A1 (en) 1986-01-03
IL75518A0 (en) 1985-10-31
WO1986000225A1 (en) 1986-01-16
MA20467A1 (en) 1985-12-31
SE8502876D0 (en) 1985-06-11
GB2161074A (en) 1986-01-08

Similar Documents

Publication Publication Date Title
LU90829I2 (en) Tepoxalin-zubrin and its pharmaceutically acceptable derivatives
LU90219I2 (en) Tolcapone and its pharmaceutically acceptable derivatives (TASMAR)
LU91039I2 (en) Proteq flu and its pharmaceutically acceptable derivatives
NO863061D0 (en) PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE PHENOXYDICOIC ACID DERIVATIVES.
LU88750I2 (en) VENLAFAXINE and its pharmaceutically acceptable derivatives
LU90484I2 (en) Novorapid - insulin aspart and its pharmaceutically acceptable salts and derivatives
FI872864L (en) Process for the preparation of pharmaceutically active benzimidazole derivatives
NL194821B (en) Pharmacologically active catechol derivatives and their compositions.
NO821645L (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE BENZOAZEPINE DERIVATIVES
NO864425D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE HETEROCYCLYLOX OTHALAZINYL ACETIC ACID DERIVATIVES.
NO854965L (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PTERIDINE DERIVATIVES.
NO865204D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BENZOIC ACID AND BENZOIC ACID DERIVATIVES.
NO852729L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE BENZIMIDAZOLE AND BENZOTIAZOLD DERIVATIVES
LU88790I2 (en) Moxidectin and its pharmaceutically acceptable derivatives
DE3263917D1 (en) Alkanesulfonanilide derivatives and pharmaceutically acceptable acid addition salts thereof
NO854369L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BENZIMIDAZOLE DERIVATIVES
NO864131D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE INDOL AND INDAZOL-KETOSULPHONE DERIVATIVES.
ATE155687T1 (en) PHARMACOLOGICALLY IMPROVED FORMULATIONS
SE8502876D0 (en) INHIBITION OF TUMOR DEVELOPMENT
FI911788A7 (en) Conjugates of difluoroglutamic acid with folates and antifolates for the treatment of neoplastic diseases
FI911778A7 (en) Difluoroglutamic acid conjugates with folates and antifolates for the treatment of neoplastic diseases
IT8219482A0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ORAL CAVITY DISEASES.
JO1451B1 (en) inhibition of tumor development
IT1096279B (en) PHARMACEUTICAL COMPOUND OF IMPROVED MUCOLITIC AND FLUIDIFYING ACTIVITY OF MUCOUS SECRETIONS
IT1143921B (en) ALCANOIC ACID DERIVATIVES EQUIPPED WITH THERAPEUTIC PROPERTIES AND PROCEDURE FOR THEIR PREPARATION

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8502876-9

Effective date: 19950110

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8502876-9

Format of ref document f/p: F